Dr. Forastiere is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287Phone+1 410-955-8964
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1978 - 1980
- University of ConnecticutResidency, Internal Medicine, 1977 - 1978
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1976 - 1977
- Hartford HospitalInternship, Transitional Year, 1975 - 1976
- New York Medical CollegeClass of 1975
Certifications & Licensure
- AZ State Medical License 1980 - Present
- FL State Medical License 1980 - Present
- MD State Medical License 1980 - 2026
- MI State Medical License 1982 - 1989
- PA State Medical License 1976 - 1978
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Fellow (FASCO) American Society of Clinical Oncologists, 2008
Clinical Trials
- Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer Start of enrollment: 1997 Mar 01
- Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach Start of enrollment: 1998 Jun 22
- Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer Start of enrollment: 1997 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Treatment of the neck in residual/recurrent disease after chemoradiotherapy for advanced primary laryngeal cancer.Juan P Rodrigo, Fernando López-Álvarez, Jesús E Medina, Carl E Silver, K Thomas Robbins
European Journal of Surgical Oncology. 2024-07-01 - A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.Athanassios Argiris, Yael Flamand, Panayiotis Savvides, Jennifer M Johnson, Ioannis Vathiotis
European Journal of Cancer. 2024-03-01 - 5 citationsNovel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer.Nabil F Saba, Saagar Pamulapati, Bhamini Patel, Mayur Mody, Primož Strojan
Cancers. 2023-03-24
Journal Articles
- Pattern of Planned Systemic Therapy Usage in Newly Diagnosed, Nonmetastatic Squamous Cell Carcinoma of the Head and Neck in a Commercially Insured Population in the Un...Christine G Gourin, Ranee Mehra, Hyunseok Kang, Arlene A Forastiere, Ana P Kiess, Head & Neck
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: